Construction and Expression of a Recombinant Adenovirus Encoding E6-E7 Fusion Proteins of Hmnan Papillomavirus Subtypes 16, 18, and 58
杨峥嵘,马原栋,万骏,郑义,王海峰,赵洁,彭扬洋,罗海波,羊东晔,黄来强
DOI: https://doi.org/10.3969/j.issn.1000-8861.2008.04.024
2008-01-01
Abstract:Objective To construct a recombinant adenovirus which could expressing E6-E7 fusion proteins of human papillomavirus subtypes 16,18, and 58, for developing therapeutic candidate vaccines best suited to Chinese patients in the next step. Methods E6-E7 fusion genes of human papillomavirus subtypes 16, 18, and 58 were amplified and constructed through conventional molecular biology technology. Site-directed mutagenesis was introduced for abolishing the transforming activity of E6-E7 fusion, while the effects of mutation were also confirmed by cell culture test, anchorage independent growth, and tumorigenesis in nude mice. These mutated fusion genes were then ligated with Internal ribozyme entry site(IRES) and cloned into pAdeno-X vector system. The recombinant adenovirus was transfected into 293 cells and the expression of heterologous protein was analyzed by Western blotting and fluorescence microscopy. Results Sequences in the constructed plasmids were correct. Transforming activity of mutated E6 and E7 genes were significantly degraded in vitro and in vivo. E6-E7 fusion proteins of all three subtypes were successfully detected in cultivation supernatant of recombinant adenovirus-infected 293 cell by Western blotting. Conclusion The constructed recombinant adenovirus can express E6-E7 fusion protein of human papillomavirus subtypes 16,18, and 58 with transforming activity abolished, which might pave a way for developing a series of HPV multivalent therapeutic vaccines in the future.